Australia's most trusted
source of pharma news
Monday, 9 February 2026
Monday, 9 February 2026
Subscribe
Login
Six new drugs join review list
Six new medicines have joined the TGA's review list hinting at what could arrive in Australia later this year and it includes a first-in-class oral heart drug.
MA recruits after senior execs exit
Find out which high-profile leaders have left and what top-level jobs are up for grabs, with 'significant strategic growth' on the agenda
TODAY
First generic abortion pill arrives
Approval comes less than three years since a landmark decision to broaden access to the PBS listed medicine
TODAY Approvals Action
Aussie pharma market to surge
Strong annual growth is predicted for local pharma revenues despite headwinds from a government looking to balance the budget
6 February
Local exec scores Aussie GM role
Experienced pharma executive who's held top roles at Lilly and Novartis has been named industry's newest country leader
5 February
Boss lands new Country Head role
Ex-MD scores top new role and she's not alone with widespread movement across industry in the latest employment moves
4 February
17 pharmas hunting expansions
Find out which new indications are on the cards after the TGA accepted a bumper list of applications late last year
4 February
Latest Jobs
QC Analyst -BiochemistryMarketing ManagerSAP Project LeadLogistics ManagerFinance ManagerSenior Recruitment ConsultantDistribution and Warehouse TechnicianRecruitment Consultant33 more...
Pharma in Focus Jobs
Marketing & Communications (3)
- Marketing Manager - Sydney
- Senior Brand Manager - Sydney
- Business Analyst / Product Owner – Digital Health (EMR) - Melbourne
Sales & Customer Relations (12)
- Associate Business Development Director - Clinical Research, China - Shanghai, China
- Customer Service Representative - St Leonards
- Hospital Sales Representative - Melbourne
- Senior Territory Sales Manager - Melbourne
- Customer Service Representative - Pemulwuy
- Sales & Key Account Associate - Melbourne
- Inside Sales Specialist - Melbourne
- Key Account Manager - CNS - Sydney
- GP Sales Representative - Brisbane
- Pharmaceutical Sales Representative - Gold Coast
- Clinical Research, Business Development Manager - Shanghai, China
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
Access & Reimbursement (1)
Clinical & Medical, R&D (7)
- Medical Advisor - Sydney
- Head of Medical - Sydney
- Associate Business Development Director - Clinical Research, China - Shanghai, China
- Senior Project Director - Clinical Research - Shanghai, China
- Clinical Research, Business Development Manager - Shanghai, China
- Site Medical Director - Sydney
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
Regulatory, Pharmacovigilance & QA (4)
- Senior Quality Assurance Associate - Melbourne
- Senior Regulatory Affairs Associate - Sydney
- Pharmacovigilance and Regulatory Specialist - Melbourne
- Senior Technical & Regulatory Associate - Sydney
Executive Roles (4)
- Associate Business Development Director - Clinical Research, China - Shanghai, China
- Senior Project Director - Clinical Research - Shanghai, China
- Site Medical Director - Sydney
- Associate Business Development Director - Clinical Research, Japan - Tokyo, Japan
Other (18)
- QC Analyst -Biochemistry - Melbourne
- SAP Project Lead - Brisbane
- Logistics Manager - Sydney
- Finance Manager - Melbourne
- Senior Recruitment Consultant - Victoria
- Distribution and Warehouse Technician - Broadmeadows
- Recruitment Consultant - Sydney
- Logistics Specialist - Macquarie Park
- Warehouse Associate - Chatswood
- Chief Operating Officer - Sydney
- Chief Operating Officer - Sydney
- Dedicated Principal Agent - Pemulwuy
- Finance Administrator - Sydney
- Warehouse & Logistics Officer - Macquarie Park
- GP Rep Bundaberg Contract - Bundaberg
- Commercial Lead - Melbourne
- Commercial Lead - Melbourne
- Senior Payroll Officer - 41808-1 - Melbourne
'Aussie Luke' puts stamp on GSK
The company's newly minted Australian CEO has unveiled his game plan for the company's future success
6 February
Jobs go in latest Aussie downsize
ICYMI: The downsizing of industry continues following a company restructure plus the other most popular stories this week
6 February Your Week in 5 Minutes
Forecast sends shares tumbling
The largest pharmas in the fastest growing market are heading in two directions with one company's shares plummeting 18 per cent
6 February
2-yr wait for high priority funding
NZ is considering moving a treatment for a rare blood cancer to the first line, two years after a 'high priority' recommendation
6 February
Pharmas nab Super Bowl touchdown
American Football fans will learn about screening programs for health problems after two pharmas score top ad slots
5 February
IPA to kick off second Conference
Featuring more fast-paced, retail-driven sessions with delegates to leave with a 90-day implementation plan
5 February
Aussie Open lifts pharma's game
Gruelling match between two tennis greats holds an important lesson for pharma, according to a former ANZ GM
5 February
Fake meds trigger TGA safety alert
Laboratory testing finds "significant discrepancies" in the labelled content with the Regulator warning of accidental overdose
5 February
Patients slip through the cracks
National survey released to mark World Cancer Day today reveals critical gaps in cancer support for patients across Australia
4 February
Even better than semaglutide...
Novo may have outdone itself with a hyped combo outperforming its star T2 diabetes and obesity treatment in a head-to-head trial
4 February
Aussies drive brain cancer drug
Canadian company partners with local researchers and oncologists for a world-first clinical trial in children and adolescents
4 February
Restructure hits Aussie workforce
Business structure review hits the Australian team as company 'reshapes and redefines some employee roles'
3 February
$200M PBS market slashed in half
The government has cut the PBS list price of a major drug, following negotiations with the sponsor
3 February
Aussies win global pharma grant
Selected from a tough field of more than 80 worldwide submissions, this joint initiative by two high-profile patient groups impressed
3 February